The value of booster vaccination against COVID-19
The first vaccines against Covid-19 were approved in December 2020 and administered in the Netherlands from the beginning of January 2021. As of November 2021, The Dutch government has started its booster programme to administer an additional vaccine dose to the population.This paper discusses the current knowledge about the duration of protection of the Covid-19 vaccines that are used in the Netherlands, and the added value of booster vaccination.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:165 |
|---|---|
| Enthalten in: |
Nederlands tijdschrift voor geneeskunde - 165(2021) vom: 23. Dez. |
| Sprache: |
Niederländisch |
|---|
| Weiterer Titel: |
Boostervaccinatie tegen covid-19 |
|---|
| Beteiligte Personen: |
van Lier, Pol A C [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 14.02.2022 Date Revised 14.02.2022 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM336710712 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM336710712 | ||
| 003 | DE-627 | ||
| 005 | 20231225232747.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||dut c | ||
| 028 | 5 | 2 | |a pubmed24n1122.xml |
| 035 | |a (DE-627)NLM336710712 | ||
| 035 | |a (NLM)35138763 | ||
| 035 | |a (PII)D6623 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a dut | ||
| 100 | 1 | |a van Lier, Pol A C |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The value of booster vaccination against COVID-19 |
| 246 | 3 | 3 | |a Boostervaccinatie tegen covid-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2022 | ||
| 500 | |a Date Revised 14.02.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The first vaccines against Covid-19 were approved in December 2020 and administered in the Netherlands from the beginning of January 2021. As of November 2021, The Dutch government has started its booster programme to administer an additional vaccine dose to the population.This paper discusses the current knowledge about the duration of protection of the Covid-19 vaccines that are used in the Netherlands, and the added value of booster vaccination | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Kalkman, Shona |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nederlands tijdschrift voor geneeskunde |d 1946 |g 165(2021) vom: 23. Dez. |w (DE-627)NLM000034231 |x 1876-8784 |7 nnns |
| 773 | 1 | 8 | |g volume:165 |g year:2021 |g day:23 |g month:12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 165 |j 2021 |b 23 |c 12 | ||